2018 Compounding Pharmaceutical Manufacturing 
European Pharmaceutical Review
OCTOBER 27, 2022
Since 2018, employment numbers in the industry have grown by 11 percent, totalling $2.9 Sectors such as research, testing, medical labs and pharmaceutical manufacturing expanded greatly during the pandemic, due to high demand for COVID-19 therapeutics. To date, 747 novel compounds are in production.
pharmaphorum
MARCH 29, 2021
This is the €135 million ($165 million) REPAIR Impact Fund’s sixth call for investment proposals since it was set up in 2018, and second global call. To date, REPAIR has received over 200 investment proposals and has made nine investments in its commitment to help tackle the global AMR crisis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 21, 2022
2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Environ Sci Technol 2018, 52, 4, 1725–1734 [link].
Quality Matters
OCTOBER 13, 2021
In addition to standards for active pharmaceutical ingredients, USP also develops standards for the inactive ingredients (excipients) and other raw materials used in drug manufacturing. In a 2019 report on drug shortages, the FDA found that 62% of drug shortages occur because of quality issues in manufacturing.
Quality Matters
MAY 21, 2024
Q: Since the discovery of nitrosamines in medicines in 2018, regulatory agencies and industry members around the world have taken swift action to prevent unacceptable levels of nitrosamine impurities from forming in pharmaceuticals. A: Following the discovery of nitrosamines in 2018, USP, U.S.
Expert insights. Personalized for you.
105 
Let's personalize your content